The application of a neutralizing antibody against ANGPTL4 signaling reduced sprouting angiogenesis in the ‘ccRCC-on-a-chip’, suggesting the involvement of ANGPTL4 in ccRCC angiogenesis. Here, ANGPTL4 is linked to nonpapillary renal cell carcinoma.